ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 63 filers reported holding ADC THERAPEUTICS SA in Q4 2022. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269 | -58.3% | 300 | 0.0% | 0.00% | – |
| Q2 2023 | $645 | +10.3% | 300 | 0.0% | 0.00% | – |
| Q1 2023 | $585 | -49.2% | 300 | 0.0% | 0.00% | – |
| Q4 2022 | $1,152 | +15.2% | 300 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 300 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 300 | -14.3% | 0.00% | – |
| Q1 2022 | $5,000 | -50.0% | 350 | -30.0% | 0.00% | – |
| Q4 2021 | $10,000 | -28.6% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $14,000 | -48.1% | 500 | -54.5% | 0.00% | – |
| Q2 2021 | $27,000 | -38.6% | 1,100 | -38.9% | 0.00% | – |
| Q1 2021 | $44,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,680,149 | $24,681,000 | 9.63% |
| Grosvenor Holdings, L.L.C. | 1,517,212 | $22,288,000 | 4.35% |
| Redmile Group, LLC | 7,432,429 | $109,182,000 | 3.41% |
| MPM BioImpact LLC | 334,384 | $4,912,000 | 1.32% |
| Indie Asset Partners, LLC | 96,572 | $1,419,000 | 1.07% |
| Eventide Asset Management | 1,975,000 | $29,013,000 | 0.46% |
| HHLR ADVISORS, LTD. | 500,000 | $7,345,000 | 0.15% |
| Virtus ETF Advisers LLC | 19,193 | $282,000 | 0.13% |
| Walleye Capital LLC | 248,354 | $3,648,000 | 0.10% |
| Matrix Capital Management Company, LP | 400,000 | $5,876,000 | 0.07% |